The Role of Establishing a Multidisciplinary Team for Idiopathic Granulomatous Mastitis in Improving Patient Outcomes and Spreading Awareness about Recent Disease Trends
Table 1
The general characteristics of 44 patients diagnosed with IGM between 2002 and 2018.
Characteristics
(%)
Notes
BMI, kg/m2
Obese
16 (36.36%)
Overweight
14 (31.82%)
Normal or underweight
4 (9.09%)
Missing
10 (22.73%)
Associated comorbidity
13 (29.55%)
Diabetes mellitus
4 (9.09%)
Thyroid disorders
3 (6.82%)
Hypertension
3 (6.82%)
Hyperprolactinemia
2 (4.55%)
Atopic dermatitis
1 (2.27%)
Missing
5 (11.36%)
Menstrual status
Menstruating
44 (100%)
Parity
Parous
43 (97.73%)
37 patients (84.09%) had at least 3 previous pregnancies
Nulliparous
1 (2.27%)
Pregnancy at presentation
5 (11.36%)
Lactation at presentation
5 (11.36%)
Presence of mass
44 (100%)
Mean size: 5.8 cm (range: 1–15)
Mean duration: 3.01 months (range 0.25–18)
Presence of pain
38 (86.36%)
(Variable from mild to severe)
Abscess-like presentation
16 (36.36%)
Axillary lymphadenopathy
13 (29.55%)
Nipple retraction
3 (6.82%)
Ulcer, sinus, or fistula formation
3 (6.82%)
Extramammary findings
Erythema nodosum
3 (6.82%)
Papular rash
1 (2.27%)
Side
Left
23 (52.27%)
Right
19 (43.18%)
Bilateral
1 (2.27%)
Not recorded
1 (2.27%)
Site
Upper lateral quadrant
20 (45.45%)
Retro-areolar
15 (34.09%)
Upper medial quadrant
2 (4.55%)
Lower medial quadrant
2 (4.55%)
Not recorded
5 (11.36%)
Surgery
Wide local excision
42 (95.45%)
Mastectomy
1 (2.27%)
Prednisolone treatment
19 (43.18%)
IGM suspected clinically
31 (70.45%)
Clinical suspicion of cancer
13 (29.54%)
Data presented as frequency and percentage. BMI, Body mass index. BMI was calculated using the standard method as weight in kilograms divided by the square of height in meters. Based on the World Health Organization (WHO) classification for obesity, patients were defined as underweight (BMI < 18.5 kg/m2), normal (BMI 18.5–24.99 kg/m2), overweight (BMI ≥ 25.00 kg/m2), and obese (BMI ≥ 30.00 kg/m2) [World Health Organization (WHO), obesity: preventing and managing the global epidemic, WHO Technical Report Series 894, Geneva, Switzerland, 2000].
